SUBHASH BOSE: Open Payments
NPI 1366624421 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$117 in 5 payments from 3 companies in 2025. Trend: 2023 $385 · 2024 $134 · 2025 $117
Food & beverage: $117
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Boston Scientific Corporation | 1 | $26 |
Products named: Ozempic, CAPLYTA, WATCHMAN Access System.
Industry payments across MD — which companies pay providers there.
